跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 81,931 条关于
“Breakthrough Therapy Designation”
全部
81,931
临床试验
54,837
药物
4,644
机构
118
资讯
22,332
2年前
Sunvozertinib Granted FDA Breakthrough Therapy Designation for First-Line EGFR Exon 20 Insertion-Positive NSCLC
去年
Nipocalimab Receives Second FDA Breakthrough Therapy Designation for Sjögren's Disease
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation for Advanced Melanoma
3年前
Glecirasib Receives Breakthrough Therapy Designation in China for Pancreatic Cancer
去年
Sagimet's Denifanstat Receives FDA Breakthrough Therapy Designation for MASH
7年前
FDA Grants Breakthrough Therapy Designation for GSK's Osteosarcoma Treatment
2年前
Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury
去年
Biogen's Felzartamab Receives FDA Breakthrough Therapy Designation for Kidney Transplant Rejection
去年
Tolebrutinib Receives FDA Breakthrough Therapy Designation for Non-Relapsing Secondary Progressive Multiple Sclerosis
去年
Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren's Disease
第 1 页，共 2234 页
上一页
下一页
